NOVEL TREATMENT OF TYPE 1 DIABETES - THE INFLUENCE OF HLA, NUMBER OF DOSES AND ADMINISTRATION ROUTE ON THE EFFECT OF GAD-SPECIFIC IMMUNOTHERAPY

Hannelius, U; Beam, C; Ludvigsson, J

DIABETES TECHNOLOGY & THERAPEUTICS, 2021; 23 (): A55